Articles On Invion (ASX:IVX)

  ASX 200 hit by afternoon profit taking, closing at +0.1pc for the day. 9 of 11 ASX sectors were higher, so… two of them weren’t. Small cap gains led by East33, and the world is their oyster.   Local markets trimmed most of the early mor...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

ASX closes almost 1.4pc higher Broad-based gains  Top small cap performers led by Vonex   The local benchmark index has lifted on Tuesday, with broad-based gains driving all 11 sectors into the green. The S&P/ASX200 closed 105.10 poi...

ASX down 0.5pc, Energy sector up due mainly to Woodside’s upgrade. CRH to acquire Adbri, ending Adbri’s 62-year ASX presence China’s data CPI keeps increasing, new data shows   The ASX continued yesterday’s decline, down another -0.5% tod...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Aussie stocks fell 1pc on rising inflation ASX sectors mostly down; IAG hit by class action lawsuit Asian markets dropped; IMF ups China’s growth forecast to 5pc   Aussie stocks fell by 1% on Wednesday, hitting their lowest point in three...

ASX 200 dips  amid Wall Street closure for Memorial Day Commodities bounce back; gold stocks rise, uranium falls Forrestania jumps on iron ore play   The ASX 200 edged down -0.2% on Tuesday as local traders navigated a directionless marke...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

ASX retreats on Tuesday ahead of Fed Budget and US PPI/CPI Copper stocks up after the metal hit highest level since 2022 GUD jumps 11pc after strong FY24 update   The ASX dipped by -0.4% on Tuesday ahead of the Federal Budget and a key PP...

ASX losses accelerate after sluggish retail sector updates  Baby Bunting, Temple & Webster, JB Hi-fi all under pressure on soft sales Alliance Nickel soars on fat federal grant   After opening modestly higher this morning, the ASX qui...

ASX rallies, with all sectors rallying on Tuesday The RBA holds rate, but keeps door open for more rate hikes Update on Bonza Airlines’ ongoing drama   The Aussie stock market rallied hard on Tuesday, up over +1%, as the RBA decided to ho...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Stockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percenta...

Local markets recover early losses to close slightly ahead Material and Financial gains offset IT and Property losses Small Caps led by ADX Energy   Aussie share markets have recovered from early losses to close Monday, ever so slightly i...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Invion (ASX:IVX) has announced the findings of a study by the Peter MaCallum Cancer Centre on the effect of its INV043, when combined with an immune checkpoint inhibitor therapy.

The ASX 200 index has retreated from its all time high levels on Monday after closing -0.15% lower. As a quick reminder, the index touched a record high of 7,769 last Friday. Sentiment fell after the ABS reported a 1.7% fall in Australian b...

Stockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percenta...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

  Local markets end +0.13% higher in quasi-comeback Consumer Staples soar on bumper Coles news, but offset by everyone else Small Caps led by Audeara on the back of a massive manufacturing sale   The indignation of Coles has led Consumer...

  Local markets end Friday (and the week) ahead circa 0.4pc IT sector booms 1.5pc Small caps led by WhiteHawk   The ASX200 has kept its head and ended Friday higher thanks to a boost from local tech stocks. At 4.15pm on Friday February 23...

The ASX benchmark has ended Wednesday higher after positive inflation data 7 of 11 sectors in the green, IT ahead by circa +2pc Small caps led by Euro Manganese The local market has trimmed the CPI fat of this morning’s gains, after the...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

The ASX benchmark has ended Thursday in a circa -0.8% hole Energy Sector, down -1.4% leads losses Small caps led by RWD   The Australian sharemarket has been trimming gains from the open on Thursday, steadily digging a hole in the red as...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

The ASX has ended Wednesday jumping almost 100 points. Huge effort, everyone Energy Sector misses out on all the positive vibes Small caps led by Findi and Firebrick Pharma   The Australian sharemarket is in fine fettle on this Wednesday...

ASX200 closes 0.9pc higher Property stocks and IT sector enjoy huge day Small caps led by DCL   The Australian sharemarket has lifted strongly on Day Two of Trading in November, the Best Month for Trading Ever. Local investors got stuck r...

Benchmark ASX index ends +0.21%, but down -2.2% this week Consumer stocks offset Tech losses Small caps led by Webcentral    The benchmark has ended another tortuous week of trade with a little Friday victory. Down -2.2% for the week, all...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today. ICYMI Leader B...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Dimerix’s drug granted QYTOVRA as brand name by US FDA Starpharma completes recruitment for VIRALEZE study in UK Invion adds South Korea to list of exclusive territories for Photosoft    FDA says QYTOVRA can be used as DMX-200 brand name...

According to the World Health Organisation (WHO), cancer is the leading cause of death globally. WHO defines cancer as a generic term for a large group of diseases that can affect any part of the body with malignant tumours and neoplasms. W...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead’s Top 10 at shortly-before-11-ish, published shortly after I’ve located my reading glasses and wiped the bacon grease off my fingers at the start of each trading day. It highlights the best (and sometimes worst) performing ASX sto...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

ASX 200 closes about 0.06% in the green (so, really, we ended in the chartreuse) down -1.2 in August Telco and IT Sectors offset Staples and Energy losses Small cap winners include 29M, CDX and HLA   Volatility, uncertainty and indecisio...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

ASX 200 benchmark rises almost 0.6% Tech Sector recovers Wednesday’s losses, after Nasdaq positivity  Miners lead small cap gains, ERW, RDN, AZS winning at home in Andover South   The Australian share market was up and about early on Thur...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Local markets have pedalled furiously since lunch to bring the benchmark to +0.35%. CBA posts record $10.2 billion profit off the back of ever-increasing interest rates. Small capper Perpetual stuns with a 50% spike after buying up land in...

ASX benchmark finishes the flat, after struggling to find traction since mid-morning Health Care romped home to win Best Sector today, up more than 0.4% Errawarra’s nearology has continued to pay off, adding around 50% more today.   Whil...

ASX sleepwalks to an underwhelming -0.3% loss for the day.  Real Estate the ‘highlight’, on a paltry +0.5% Lithium Australia’s tech-for-facilities deal with MinRes saw it climb past +80% for the session.   It’s been a weak and sorry day o...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

The ASX 200 finishes up 1.56%  The ASX XEC rises 1.52% All 11 sectors were higher lead by Real Estate   The ASX 200 managed a decent 1.56% lift today, and the ASX XEC was also in the green, up 1.52%.  All of 11 sectors were higher, led b...

S&P/ASX 200 closes well in the red today: -1.24% after US stocks dipped on the back of Fed hawkishness  Sectors-wise, IT was the only group finishing vaguely in the green, with Materials Discretionary and Financials stocks largely hamm...